SCARF1 and liver cancer: The fact that SCARF-1 is down-regulated in liver cancers, particularly those that are poorly differentiated and thus have the worst prognosis, also suggests it may play a role in tumour immune control through recruitment of inflammatory cells in response to microenvironmental signals.